Elliot C. Smith

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

What is the Prognostic Relevance of Responses Less Than a CR to Initial AML Treatment?

What is the Prognostic Relevance of Responses Less Than a CR to Initial AML Treatment?

Journal: Clinical lymphoma, myeloma & leukemia

Published: September 18, 2025

Response and clarification of: 'There is a knowledge mobilization gap in musculoskeletal injury research in the military context'.

Response and clarification of: 'There is a knowledge mobilization gap in musculoskeletal injury research in the military context'.

Journal: Journal of military, veteran and family health

Published: June 02, 2025

Who truly benefits from gilteritinib combinations in FLT3-mutated relapsed-refractory(R/R) AML: a Canadian single center analysis.

Who truly benefits from gilteritinib combinations in FLT3-mutated relapsed-refractory(R/R) AML: a Canadian single center analysis.

Journal: Blood cancer journal

Published: April 21, 2025

Utility of PSA free-to-total ratio for clinically significant prostate cancer in men with a PSA level of <4 ng/mL.

Utility of PSA free-to-total ratio for clinically significant prostate cancer in men with a PSA level of <4 ng/mL.

Journal: BJU international

Published: November 28, 2024

Evolution from an antecedent chronic myeloid malignancy does not impact survival outcomes in NPM1-mutated AML.

Evolution from an antecedent chronic myeloid malignancy does not impact survival outcomes in NPM1-mutated AML.

Journal: European journal of haematology

Published: April 10, 2024

Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study.

Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study.

Journal: Bone marrow transplantation

Published: January 26, 2024

Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study.

Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study.

Journal: Bone marrow transplantation

Published: August 24, 2023

Management of Mixed Warm/Cold Autoimmune Hemolytic Anemia: A Case Report and Review of Current Literature.

Management of Mixed Warm/Cold Autoimmune Hemolytic Anemia: A Case Report and Review of Current Literature.

Journal: Case reports in hematology

Published: April 06, 2023

Quantifiable brain atrophy synthesis for benchmarking of cortical thickness estimation methods.

Quantifiable brain atrophy synthesis for benchmarking of cortical thickness estimation methods.

Journal: Medical image analysis

Published: December 13, 2021

Advancing Traditional Prostate-specific Antigen Kinetics in the Detection of Prostate Cancer: A Machine Learning Model.

Advancing Traditional Prostate-specific Antigen Kinetics in the Detection of Prostate Cancer: A Machine Learning Model.

Journal: European urology focus

Published: September 07, 2021

Association of frailty with clinical outcomes in myelofibrosis: a retrospective cohort study.

Association of frailty with clinical outcomes in myelofibrosis: a retrospective cohort study.

Journal: British journal of haematology

Published: March 28, 2021

Risk of hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients with myeloproliferative neoplasms treated with ruxolitinib.

Risk of hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients with myeloproliferative neoplasms treated with ruxolitinib.

Journal: Leukemia & lymphoma

Published: January 18, 2021

Showing 1-12 of 26

Last Updated: 09/26/2026